1499 related articles for article (PubMed ID: 32117257)
1. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
2. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
[TBL] [Abstract][Full Text] [Related]
3. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
Coppola M; Ottenhoff TH
Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
[TBL] [Abstract][Full Text] [Related]
4. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia.
Riaño F; Arroyo L; París S; Rojas M; Friggen AH; van Meijgaarden KE; Franken KL; Ottenhoff TH; García LF; Barrera LF
Tuberculosis (Edinb); 2012 Mar; 92(2):148-59. PubMed ID: 22226907
[TBL] [Abstract][Full Text] [Related]
5. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
Pathakumari B; Devasundaram S; Maddineni P; Raja A
Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
[TBL] [Abstract][Full Text] [Related]
6. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
8. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4
Boillat-Blanco N; Tumbo AN; Perreau M; Amelio P; Ramaiya KL; Mganga M; Schindler C; Gagneux S; Reither K; Probst-Hensch N; Pantaleo G; Daubenberger C; Portevin D
Immun Inflamm Dis; 2018 Jun; 6(2):345-353. PubMed ID: 29642283
[TBL] [Abstract][Full Text] [Related]
10. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
11. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
13. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
[TBL] [Abstract][Full Text] [Related]
14. Study of CD27 and CCR4 Markers on Specific CD4
Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
Front Immunol; 2018; 9():3094. PubMed ID: 30687314
[TBL] [Abstract][Full Text] [Related]
15. PD-1 Expression on
Day CL; Abrahams DA; Bunjun R; Stone L; de Kock M; Walzl G; Wilkinson RJ; Burgers WA; Hanekom WA
Front Immunol; 2018; 9():1995. PubMed ID: 30233588
[TBL] [Abstract][Full Text] [Related]
16. Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.
Commandeur S; Coppola M; Dijkman K; Friggen AH; van Meijgaarden KE; van den Eeden SJ; Wilson L; van der Ploeg-van Schip JJ; Franken KL; Geluk A; Ottenhoff TH
PLoS One; 2014; 9(6):e99203. PubMed ID: 24905579
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
18. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
Day CL; Moshi ND; Abrahams DA; van Rooyen M; O'rie T; de Kock M; Hanekom WA
PLoS One; 2014; 9(4):e94949. PubMed ID: 24740417
[TBL] [Abstract][Full Text] [Related]
19. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
20. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
